FTC Sues Private Equity-Owned Anesthesia Company for Illegal Monopolization, Causing Major Price Hikes for Patients
-
FTC sued private equity-backed anesthesia staffing company USAP, accusing it of illegally monopolizing the Texas market over 10 years.
-
FTC alleges USAP's acquisitions of anesthesia practices led to egregious price increases for patients, tens of millions in excess costs.
-
Suit follows FTC chair Lina Khan's comments that agency would investigate anticompetitive practices among private equity-acquired companies.
-
FTC says USAP's reimbursement rates are double the median anesthesia provider rate in Texas.
-
Research shows patient costs rise after private equity firms acquire physician practices, including 26% increase for anesthesia after buyouts.